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Abstract  33 
Background: The existence of a cause-effect relation between active smoking and new-onset 34 
asthma in adults, although supported by several studies, has not been proven yet. 35 
Aims: To prospectively study asthma incidence as a function of smoking habits in the Italian adult 36 
population. 37 
Methods: A population-based cohort of 5,241 non-asthmatics was enrolled in Verona and Sassari 38 
in 1998–2000. The cohort was contacted again in 2007–2009 within the Gene-Environment 39 
Interactions in Respiratory Diseases study, and 3,187 subjects (60.8%) answered a screening 40 
questionnaire on smoking habits and respiratory disorders. The relation between smoking habits 41 
and self-reported new-onset asthma, defined as asthma attacks/use of medicines for asthma, was 42 
investigated by a multivariable logistic model. 43 
Results: During follow-up 145 new cases of asthma were observed, yielding a cumulative 44 
incidence of 4.6% (95% CI 3.9–5.4); cumulative incidence of asthma did not significantly differ 45 
among never smokers (76/1,666=4.6%), ex-smokers (30/554=5.4%) and current smokers 46 
(39/883=4.4%) (p=0.641). In multivariable analysis the most important risk factor for asthma 47 
onset was allergic rhinitis (OR=4.00, 95% CI 3.68–4.35). Compared to never smokers, the risk of 48 
asthma onset was slightly increased in ex-smokers (OR=1.28, 1.09–1.49) but not in current 49 
smokers (OR=1.01, 0.66–1.53). Current smoking became a significant predictor only when both 50 
new-onset wheezing and new-onset asthma were considered as outcome (OR=2.03, 1.35–3.05). 51 
Conclusions: In this prospective study current smoking was not a risk factor for new-onset 52 
asthma, unless new-onset wheezing was also considered. The increase in asthma incidence among 53 
ex-smokers was likely due to reverse causation.  54 
  55 
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 Introduction 56 
 The effect of smoking on asthma onset in adults is still a matter of debate. Most longitudinal 57 
studies found an increased risk of new-onset asthma among current smokers with respect to never 58 
smokers [1–7], the relative risk ranging between 1.4 and 3. However a few studies report no effect 59 
of current smoking on asthma onset [8–11], or even a protective effect [12]. A few studies found 60 
different effects according to gender: an increased incidence of asthma among current smokers has 61 
been found only in women by some Western studies [13,14] and only in men by a Japanese study 62 
[15]. 63 
 A recent report of Surgeon General by the Centers for Disease Control and Prevention [16] 64 
concluded that “the evidence is sufficient to infer a causal relationship between active smoking 65 
and exacerbation of asthma in adults”, but not “between active smoking and incidence of asthma”, 66 
as “the evidence is suggestive but not sufficient”.  67 
 The current literature [7,10,16] found several reasons that could bias the estimates of the 68 
smoking-asthma association and lead to discrepant reports: 69 
1) The “healthy smoker effect” could reduce smoking initiation or favor smoking cessation 70 
among people more susceptible to smoking noxious effects [17]. 71 
2) The definition of asthma adopted can largely influence the results: for instance in the 72 
British 1958 birth cohort current smoking was associated with incident asthma only when 73 
wheezing was also considered as an outcome [18]. Likewise in Swedish adolescents ever 74 
smoking turned out to be a risk factor for wheezing but not for asthma [19]. In the elderly 75 
the relation between smoking and asthma onset could be biased by a misclassification 76 
between asthma and COPD [1]. 77 
3) Passive smoking has been reported to increase the risk of adult-onset asthma among never 78 
smokers [7]. In most studies passive smoking among never smokers has been seldom 79 
considered, possibly causing an underestimation of active smoking on asthma incidence. 80 
4) Considering smoking status at baseline could not be adequate, if a substantial proportion of 81 
the studied population change his smoking behavior during the follow-up. Hence, some 82 
authors [10] handled smoking as a time-dependent variable in statistical analysis. 83 
5) Not taking into account socioeconomic status as a potential confounder could bias the 84 
estimates of smoking-asthma association. Indeed in the late phase of smoking epidemic, 85 
cigarette smoking becomes mainly confined to lower socioeconomic classes [20], who in 86 
turn are at high risk for respiratory diseases [21]. 87 
In addition, the association between smoking and asthma can be modified by atopic status and 88 
this effect modification could contribute to discrepancies observed in the current literature. In the 89 
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European Community Respiratory Health Survey (ECRHS) the incidence of adult-onset asthma 90 
was higher in smokers than in nonsmokers among the atopics (OR=1.45, 95% CI 0.81–2.61), 91 
while an opposite trend was observed among nonatopics (OR=0.67, 0.40–1.15) [11]. Accordingly, 92 
an increased risk of asthma onset among smokers was found in an Italian cohort of subjects with 93 
allergic rhinitis [22]. At variance, in a Swedish study [2] the odds ratio (OR) of asthma onset in 94 
smokers with respect to nonsmokers increased from 1.8 (0.8–4.2) among atopics to 5.7 (1.7–19.2) 95 
among nonatopics. 96 
 The impact of smoking on asthma onset in adults was prospectively investigated, using data 97 
from the Gene-Environment Interactions in Respiratory Diseases (GEIRD) study [23]. In addition, 98 
it was verified whether the smoking-asthma relation was modified by allergic rhinitis (a proxy of 99 
atopy) [24], change in smoking definition (smoking status assessed at baseline only or both at 100 
baseline and at the end of follow-up), change in asthma definition (asthma attack/asthma drug vs 101 
asthma attack/asthma drug/wheezing) and adjustment for occupational status.  102 
 103 
 Materials and Methods 104 
 Recruitment of studied cohorts  105 
 The incidence of asthma and its determinants were studied in three population-based cohorts. 106 
Two cohorts had been recruited in the frame of the Italian Study on Asthma in Young Adults 107 
(ISAYA) in Verona, Northern Italy, and Sassari, Mediterranean island of Sardinia [25]. The third 108 
cohort had been recruited in the frame of the Italian Study on the Incidence of Asthma (ISIA) in 109 
Verona [12]. Briefly ISAYA cohorts originated from samples of 3,000 subjects (1,500 males, 110 
1,500 females) randomly selected from the general population aged 20–44 years and were 111 
comprised of responders to a screening questionnaire administered first by mail and then by phone 112 
in 1998–2000. The questionnaire enquired about socio-demographic characteristics, respiratory 113 
symptoms, smoking habits and socioeconomic burden [26]. 114 
 The recruitment of the ISIA cohort was more complex, as the cohort originated from a random 115 
sample selected in Verona with the same protocol in the frame of the ECRHS. The 2,713 116 
responders to the ECRHS screening questionnaire in 1991–93 were contacted again in 1998–2000 117 
and administered the same questionnaire used in ISAYA. 118 
 Response percentage had been 63% (1712/2713) in Verona-ISIA, 74% (2166/2927) in Verona-119 
ISAYA and 70% (2055/2925) in Sassari-ISAYA. At the baseline in 1998-2000 the three cohorts 120 
were comprised of 5,933 subjects overall. 121 
 Assessment of asthma and other respiratory disorders at baseline 122 
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Subjects with current or past asthma at baseline were excluded from the analysis. “Current 123 
asthma” was assumed when a subject reported having asthma attacks during the last 12 months or 124 
currently taking medicines for asthma. “Past-asthma” was considered present when a subject 125 
reported ever asthma during the lifespan, but neither attack during the previous year nor currently 126 
taking medicines for asthma.  127 
 In the main analysis, “incident asthma” was defined as a new case of current asthma reported at 128 
follow-up. Incident cases were considered also those subjects whose asthma developed during 129 
follow-up and underwent remission during the same period.  130 
 Other respiratory disorders were considered as potential determinants of asthma onset: asthma-131 
like symptoms, allergic rhinitis and chronic bronchitis. Asthma-like symptoms included wheezing, 132 
tightness in the chest, and shortness of breath in the last 12 months. A subject who did not have 133 
asthma but reported at least one asthma-like symptom, was categorized as having asthma-like 134 
symptoms. Allergic rhinitis was defined by a positive answer to the question “Do you have any 135 
nasal allergies including hay fever?". Chronic bronchitis was assumed if the subject answered 136 
affirmatively to the question “Have you had cough and phlegm on most days for a minimum of 137 
three months a year and for at least two successive years?".  138 
Selection and follow-up of non-asthmatic cohorts 139 
Of 5,933 subjects who had participated in the baseline study, 692 subjects were excluded because 140 
they had either current (n = 309) or past (n = 322) asthma at baseline or lacked information on 141 
asthma status (n = 61). Hence new onset of asthma and its determinants were prospectively 142 
investigated in 5,241 subjects without a history of asthma at baseline. Of note, subjects with 143 
asthma-like symptoms but without current/past asthma were retained. 144 
In 2008–09 subjects who had participated in ISAYA or ISIA were administered by mail/phone the 145 
GEIRD screening questionnaire, which is the same as the previous one with the addition of 146 
questions on education level, outdoor exposure, history of asthma, rhinitis, chronic bronchitis and 147 
eczema, and life impairment [23] (available at http://www.geird.org). Duration of follow-up was 148 
9.1 ± 0.8 years (mean ± SD) (median 9.4, interquartile range 8.5–9.7). 149 
 Assessment of smoking habits 150 
 Subjects were considered: 1) current smokers if they reported to have smoked at least one 151 
cigarette per day or one cigar a week for a year, and also in the last month; 2) ex-smokers if they 152 
had smoked at least one cigarette per day or one cigar a week for a year, but not in the last month; 153 
3) never smokers otherwise. To evaluate cumulative smoke exposure, pack-years were calculated 154 
as years of smoking multiplied by the average daily consumption of 20-cigarette packs. Self-155 
reported smoking status had been validated in the survey performed in Verona in 1991–93, where 156 
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a good agreement (Cohen’s k = 0.93) had been found between self-reported smoking consumption 157 
and serum cotinine levels [27]. 158 
 To evaluate changes in smoking habits, subjects were also classified as follows [28]: 1) never 159 
smoker (if so at both surveys), 2) starter/restarter  if a never smoker or ex-smoker at baseline 160 
reported to be a smoker at follow-up, 3) ex-smoker if a never smoker at baseline became an ex-161 
smoker at follow-up or an ex-smoker remained an ex-smoker, 4) quitter if a current smoker 162 
became an ex-smoker at follow-up and 5) current smoker, if so at both surveys. Subjects having 163 
inconsistent answers were excluded from the analysis (90 subjects).  164 
 Statistical analysis  165 
 To evaluate significance of differences among different groups (responders/non-responders, 166 
never/ex/current smokers) the Fisher’s exact test or chi-squared test were used for categorical 167 
variables and the Wilcoxon-Mann-Whitney rank-sum test for continuous variables. Verona was 168 
considered as two separated cohorts, Verona-ISIA and Verona-ISAYA. 169 
 To compute asthma incidence, timing of first asthma attack was considered. Information on the 170 
date of asthma onset had not been reported by 32.1% of new cases (48/145), for these subjects the 171 
middle of the follow-up was assumed as time to event. 172 
 A logistic regression model was used to estimate the influence of smoking habits and 173 
respiratory disorders (asthma-like symptoms, allergic rhinitis, chronic bronchitis) at baseline on 174 
asthma onset during the follow-up, controlling for gender, age class (20–29, 30–39, 40–54 years), 175 
occupation (clerk, businessman, workman, unemployed, housewife, student, other). Standard 176 
errors were adjusted for intra-cohort correlation. Significance of the interaction between smoking 177 
habits and the other variables in the model was also tested. 178 
 A sensitivity analysis was performed by modifying the outcome or the main explanatory 179 
variable tested. First, the analysis was repeated by considering as outcome not only the onset of 180 
current asthma but also the onset of wheezing; for this purpose, only subjects without both 181 
current/past asthma and wheezing were included in the analysis (n = 2,850). Second, the analysis 182 
was repeated by using the smoking definition which took into account also changes in smoking 183 
status during the follow-up. 184 
 Stata(R) software (Texas, USA, version 13.0) was used for statistical analysis, and statistical 185 
significance was set at p < 0.05. 186 
 187 
 Results 188 
 At baseline the age of the cohort was 34.7 ± 7.8 years (mean ± SD) (range: 20-54 years) and the 189 
proportion of men was 45%. 190 
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 Response to the follow-up 191 
 Out of 5,241 subjects without current/past asthma at baseline, 3,187 answered the screening 192 
questionnaire at follow-up. Participation in the follow-up survey was higher in Verona, ranging 193 
from 68 to 77%, than in Sassari (40%) (Table 1). Response percentage was higher in women and 194 
lower in unemployed and students, and increased with advancing age. The association between 195 
respiratory disorders and participation rate was not consistent, as subjects with asthma-like 196 
symptoms were more likely to respond, while those with chronic bronchitis were less likely. As 197 
regards smoking habits, response percentage was the highest among never smokers and the lowest 198 
among current smokers (Table 1). 199 
 Baseline characteristics of responders to follow-up according to baseline smoking status 200 
 Among responders to follow-up, 28.7% (910/3167) were current smokers at baseline. They had 201 
started smoking at the age of 17.6 ± 3.6 years (mean ± SD), corresponding to a smoking duration 202 
of 17.7 ± 8.3 years, consumed 12.7 ± 7.9 cigarettes/day and had a median cumulative smoking 203 
exposure of 9.1 pack-years with an interquartile range (IQL) of 3.9–17.9. 47.1% (425/902) of 204 
current smokers consumed more than 10 cigarettes/day. Ex-smokers had quitted smoking for a 205 
median of 8.3 years (IQL 3.1–14.0).  206 
 Current smoking was more prevalent among men as expected (Table 2). Overall ever smokers 207 
(current + ex-smokers) increased with increasing age, but while ex-smokers were one fourth of 208 
current smokers in people aged 20–29 years, they approached the number of current smokers in 209 
people aged 40–54 years. Accordingly, ex-smokers were more prevalent in the older cohort 210 
(Verona-ISIA). Both current and past smoking was more common among workmen and 211 
businessmen. The proportion of current smokers was the lowest among housewives, while ex-212 
smokers were rather rare among students and unemployed. Smoking habits were significantly 213 
associated with respiratory disturbances. About half the subjects reporting asthma-like symptoms 214 
or chronic cough and sputum were current smokers, while this proportion decreased to 23% 215 
among people reporting allergic rhinitis. 216 
 Cumulative incidence and incidence rate of asthma during the follow-up  217 
 During the follow-up 145 new cases of asthma were observed, yielding a cumulative incidence 218 
of 4.6% (95% CI 3.9–5.4). Incidence rate of asthma was 5.2/1,000 person-years, 4.9/1,000 person-219 
years in men and 5.5/1,000 person-years in women. 220 
 Cumulative incidence was not significantly affected by centre, sex, age, occupation  (Table 3). 221 
Cumulative incidence of asthma was doubled in people with asthma-like symptoms and increased 222 
three-folds in people with allergic rhinitis (p<0.001). Also people with chronic bronchitis 223 
experienced a 50% increase in asthma incidence, but the effect was not significant. As regards 224 
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smoking habits, cumulative incidence in ex-smokers (30/554=5.4%) was slightly higher, although 225 
not significantly, than in current smokers (39/883=4.4%) and never smokers (76/1,666=4.6%) 226 
(p=0.641). 227 
 The pattern of risk estimates was partly modified in multivariable analysis, after adjusting for 228 
other potential determinants. Allergic rhinitis was confirmed as the most important risk factor for 229 
asthma onset, but the presence of asthma-like symptoms, although increasing the OR of asthma 230 
onset by 80%, was no longer significant. New significant risk factors emerged: with respect to 231 
never smokers, the risk of asthma onset was increased in ex-smokers (OR=1.28, 1.09–1.49) but 232 
not in current smokers (OR=1.01, 0.66–1.53). In addition, the risk of asthma onset  significantly 233 
varied across different cohorts, and it was slightly decreased among housewives.  234 
 The relation between smoking habits and asthma incidence did not change when occupation 235 
was not included in the multivariable model. Indeed the ORs of asthma incidence in ex- or current 236 
smokers with respect to never smokers were substantially unchanged: 1.24 (1.07–1.44) and 1.04 237 
(0.75–1.44) respectively. 238 
No significant interaction was detected between smoking habits and any of the other factors 239 
considered. Of note, the increase in asthma incidence, observed among ex-smokers with respect to 240 
never or current smokers, was confined to subjects with allergic rhinitis or with asthma-like 241 
symptoms (Table 4). 242 
 Changes in smoking habits classification or in outcome definition 243 
 When smoking habits were re-classified by considering smoking both at baseline and at follow-244 
up, the risk of new-onset asthma was significantly increased neither in ex-smokers at baseline nor 245 
in those quitting smoking during the follow-up (Table 5). On the other hand, the influence of 246 
allergic rhinitis and centre on new-onset asthma remained unchanged 247 
 Among the 3,187 subjects without current/past asthma at baseline and taking part in the follow-248 
up, 332 reported wheezing at baseline. Hence, the composite outcome of new asthma onset and 249 
new wheezing onset was investigated on 2,855 subjects without asthma or wheezing at baseline. 250 
With this enlarged outcome, new cases during the follow-up were 311, yielding a cumulative 251 
incidence of 10.9% (9.8–12.0%). With this new approach current smoking became a strong 252 
predictor of new-onset asthma/wheezing doubling the risk of asthma incidence (OR = 2.03, 1.35–253 
3.05), while ex-smoking lost its significance (OR = 1.04, 0.75–1.43). 254 
 255 
 Discussion 256 
 The main results of the present study are: 257 
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1. The incidence of asthma was not affected by active smoking. The result was consistent among 258 
subjects with or without allergic rhinitis, did not change after adjusting for socio-economic 259 
status, or when considering people smoking both at baseline and at follow-up. 260 
2. Current smoking at baseline became a significant risk factor only when the outcome was 261 
expanded to include both new-onset asthma and new-onset wheezing. 262 
3. Ex-smokers experienced a higher risk of asthma onset. The increased risk seemed to be 263 
confined to ex-smokers with asthma-like symptoms or allergic rhinitis, although the 264 
interactions between smoking habits and respiratory disorders were not significant. 265 
4. Allergic rhinitis was the most important risk factor for asthma incidence. 266 
 Both the asthma-smoking and smoking-asthma relations presented a high variability in the 267 
current literature, with studies yielding even opposite results. While the effect of asthma on 268 
smoking initiation is expected to largely change according to the cultural background and health 269 
education [29], the large variability in the effect of smoking on asthma is more difficult to explain. 270 
Anyway, several reasons have been put forward to explain also the latter variability: the “healthy 271 
smoker effect” [17], different definitions of asthma [18,19], considering smoking status as a static 272 
variable measured at baseline or as a time-dependent variable [10], a confounding effect of socio-273 
economic status [20,21], effect modification by atopic status [2,11]. 274 
 In the present study the impact of the healthy smoker effect was likely attenuated by the long 275 
time elapsed since smoking initiation (mean ± SD = 17.7 ± 8.3 years). The risk of asthma 276 
incidence was about the same among never and current smokers, regardless of whether current 277 
smokers were those smoking at baseline, or those smoking both at baseline and at follow-up. The 278 
relation between smoking habits and asthma incidence did not change irrespective of including or 279 
excluding occupation in the multivariable model. The relation was not modified by allergic 280 
rhinitis, a proxy of atopy [24], as denoted by the lack of a significant interaction between smoking 281 
habits and allergic rhinitis. 282 
Current smoking at baseline became a strong predictor  (OR=2.03, 1.35–3.05) only when the 283 
outcome definition was expanded to include also new onset of wheezing, in agreement with 284 
previous studies on adults [18] or adolescents [19]. 285 
In the present study, past smoking was associated with a small but significant increase in 286 
asthma incidence. In the current literature ex-smokers have been reported to present both an 287 
increase [3,5,9,14], a decrease [12], or no change [8,13] in asthma incidence. Of note, the increase 288 
in asthma incidence recorded in the present survey (OR=1.28, 1.09–1.49) was lower than the 289 
increase reported by the former studies, where the OR ranged from 1.49 (1.12–1.97) [14] to 2.50 290 
(1.58–3.96) [5]. 291 
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It is well known that most asthmatic subjects also suffer from allergic rhinitis [24,30]. In the 292 
present study allergic rhinitis at baseline emerged as the most important risk factor for new-onset 293 
asthma, being associated with a four-fold increase in asthma incidence, similarly to a previous 294 
prospective Italian study [12]. Interestingly, this effect persisted, although to a lesser extent, when 295 
allergic rhinitis during childhood was put in relation with asthma incidence during adulthood [31]. 296 
However, most GPs are not aware of the importance of AR as a risk factor for asthma [32]. 297 
 Strengths and limitations 298 
 The main strength of the present study is its prospective design which allows to elucidate the 299 
temporal relation between smoking and asthma. This is particularly important as not only smoking 300 
habits could influence asthma incidence and prognosis, but also asthma in childhood can influence 301 
smoking initiation among teenagers [29]. Moreover the analysis took into account several 302 
potential confounders and/or effect modifiers (allergic rhinitis, socio-economic status, changes in 303 
smoking habits during the follow-up). 304 
The present study has some limitations. First, only 61% of eligible subjects participated in the 305 
follow-up, and response was affected by nearly all variables considered, including respiratory 306 
disorders and smoking habits: response percentage was lower among current smokers, as expected 307 
[33]. Hence, although a recent study reported that loss to follow-up, while affecting prevalence 308 
estimates, does not modify exposure-outcome associations [34], the present findings should be 309 
interpreted with caution. 310 
Second, the lack of association between current smoking and new onset asthma could be 311 
attributed to the limited power of the present study. Indeed, a sample of 3187 subjects, of whom 312 
30% are exposed to the risk factor considered, has an 81% power to detect an increase in 313 
cumulative incidence of at least 57% (from 4.6% to 7.2%) with a 5% significant level. 314 
Nevertheless, the study power of the present study was enough to assess as significant the mild 315 
association between past smoking and new onset asthma: compared to never smokers, the OR of 316 
asthma onset was 1.28 (95% CI 1.09-1.49) in ex-smokers (p=0.002). 317 
Third, in the present survey an abstinence of just one month was required to define an ex-318 
smoker according to the ECRHS questionnaire [26] and the shortness of this time period his could 319 
have favored reverse causation. Fourth, smoking habits was assessed by questionnaire. However, 320 
in one cohort (Verona-ISIA) self-reported smoking consumption had been verified by serum 321 
cotinine levels and a good agreement had been found (Cohen’s k = 0.93) [27]. 322 
 323 
Conclusions 324 




 Notwithstanding the relatively high loss to follow-up, the present study suggests that current 327 
smoking does not affect the incidence of asthma when a rigorous definition of asthma is adopted, 328 
based on asthma attacks and use of medicines for asthma. This negative finding persisted when 329 
controlling for potential confounders, such as socioeconomic status, and for potential effect 330 
modifiers, such as allergic rhinitis, or when considering smoking status both at baseline and at 331 
follow-up. Current smoking was a strong risk factor only when a composite end-point was 332 
considered by joining new-onset asthma and new-onset wheezing. 333 




Acknowledgements:  336 
Members of the GEIRD study group: R. de Marco, G. Verlato, M.E. Zanolin, S. Accordini, O. 337 
Bortolami, M. Braggion, V. Cappa, L. Cazzoletti, P. Girardi, F. Locatelli, A. Marcon, E. Montoli, 338 
M. Rava, R. Vesentini (Unit of Epidemiology and Medical Statistics, University of Verona, Italy); 339 
M. Ferrari, L. Donatelli, C. Posenato, V. Lo Cascio (Section of Internal Medicine, University of 340 
Verona); L. Perbellini, M. Olivieri, J. D’Amato, E. Donatini, M. Martinelli (Unit of Occupational 341 
Medicine, Azienda Ospedaliera ‘‘Istituti Ospitalieri di Verona’’); P.F. Pignatti, C. Bombieri, M.D. 342 
Bettin, E. Trabetti (Unit of Biology and Genetics, University of Verona); A. Poli, M. Nicolis, S. 343 
Sembeni (Unit of Hygiene and Preventive, Environmental and Occupational Medicine, University 344 
of Verona); L. Antonicelli, F. Bonifazi (Dept of Internal Medicine, Immuno-Allergic and 345 
Respiratory Diseases, Ospedali Riuniti di Ancona); F. Attena, V. Galdo (Dept of Public, Clinical 346 
and Preventive Medicine, II University of Naples); V. Bellia, S. Battaglia (Dept of Medicine, 347 
Pneumology, Physiology and Human Nutrition, University of Palermo); I. Cerveri, A.G. Corsico, 348 
F. Albicini, E. Gini, A. Grosso (Division of Respiratory Diseases, IRCCS Policlinico ‘‘San 349 
Matteo’’, University of Pavia), A. Marinoni, S. Villani, V. Ferretti (Dept of Health Sciences, 350 
University of Pavia); L. Casali, A. Miniucchi (Dept of Internal Medicine, Section of Respiratory 351 
Diseases, University of Perugia); L. Briziarelli, M. Marcarelli (Dept of Medical-Surgical 352 
Specialties and Public Health, University of Perugia); M.G. Panico (National Health Service, 353 
Epidemiology Unit, ASL 2, Salerno); P. Pirina, A.G. Fois, F. Becciu, A. Deledda, V. Spada 354 
(Institute of Respiratory Diseases, University of Sassari); M. Bugiani, A. Carosso, P. Piccioni, G. 355 
Castiglioni (National Health Service, CPA-ASL TO2, Unit of Respiratory Medicine and 356 
Allergology, Turin); R. Bono, R. Tassinari, G. Trucco (Dept of Public Health and Microbiology, 357 
University of Turin); G. Rolla, E. Heffler (Dept of Biomedical Sciences and Human Oncology, 358 
University of Turin); E. Migliore (Centre of Oncologic Prevention, Turin). 359 
The Authors are grateful to the late Roberto de Marco for his scientific enthusiasm and insight. 360 
Ethical approval 361 
Ethics approval was obtained in each centre involved in GEIRD study from the appropriate ethics 362 
committee (Comitato di Bioetica dell’Azienda Sanitaria Locale di Sassari; Comitato Etico per la 363 
Sperimentazione dell'Azienda Ospedaliera Istituti Ospitalieri di Verona). All participants were 364 
fully informed about all aspects of the research project and consented to complete and return the 365 
questionnaire. 366 




[1] Godtfredsen NS, Lange P, Prescott E, Osler M, Vestbo J: Changes in smoking habits and 369 
risk of asthma: a longitudinal population based study. Eur Respir J 2001, 18:549–554. 370 
[2] Plaschke P, Janson C, Norrman E, Björnsson E, Ellbjär S, Järvholm B: Onset and 371 
remission of allergic rhinitis and asthma and the relationship with atopic sensitization and 372 
smoking. Am J Respir Crit Care Med 2000, 162:920–4. 373 
[3] Lundbäck B, Rönmark E, Jönsson E, Larsson K, Sandström T: Incidence of physician-374 
diagnosed asthma in adults - A real incidence or a result of increased awareness? Report from 375 
the obstructive lung disease in Northern Sweden studies. Respir Med 2001, 95:685–692. 376 
[4] Torén K, Olin AC, Hellgren J, Hermansson B: Rhinitis increase the risk for adult-onset 377 
asthma - a Swedish population-based case-control study (MAP-study). Respir Med 2002, 378 
96:635–641. 379 
[5] Pallasaho P, Juusela M, Lindqvist A, Sovijärvi A, Lundbäck B, Rönmark E: Allergic 380 
rhinoconjunctivitis doubles the risk for incident asthma - results from a population study in 381 
Helsinki, Finland. Respir Med 2011, 105:1449–56. 382 
[6] Vignoud L, Pin I, Boudier A, Pison C, Nadif R, Le Moual N, Slama R, Makao MN, 383 
Kauffmann F, Siroux V: Smoking and asthma: disentangling their mutual influences using a 384 
longitudinal approach. Respir Med 2011;105:1805–14. 385 
[7] Coogan PF, Castro-Webb N, Yu J, O'Connor GT, PaInner JR,  Rosenberg L: Active and 386 
passive smoking and the incidence of asthma in the Black Women's Health Study. Am J 387 
Respir Crit Care Med 2015;191:168-76. 388 
[8] Huovinen E, Kaprio J, Koskenvuo M: Factors associated to lifestyle and risk of adult 389 
onset asthma. Respir Med 2003;97:273–80. 390 
[9] Ekerljung L, Rönmark E, Larsson K, Sundblad B, Bjerg A, Ahlstedt S, Dahlén S, 391 
Lundbäck, B: No further increase of incidence of asthma: incidence, remission and relapse of 392 
adult asthma in Sweden. Respir Med 2008;102:1730–6. 393 
[10] Torén K, Ekerljung L, Kim J, Hillström J, Wennergren G, Rönmark E, Lötvall J, 394 
Lundbäck B: Adult-onset asthma in west Sweden-incidence, sex differences and impact of 395 
occupational exposures. Respir Med 2011;105:1622–8. 396 
[11] Antó JM, Sunyer J, Basagaña X, Garcia-Esteban R, Cerveri I, de Marco R, Heinrich J, 397 
Janson C, Jarvis D, Kogevinas M, Kuenzli N, Leynaert B, Svanes C, Wjst M, Gislason T, 398 
Burney P: Risk factors of new-onset asthma in adults: a population-based international cohort 399 
study. Allergy 2010;65:1021–30. 400 
14 
 
[12] de Marco R, Locatelli F, Cazzoletti L, Bugianio M, Carosso A, Marinoni A: Incidence 401 
of asthma and mortality in a cohort of young adults: a 7-year prospective study. Respir Res 402 
2005, 6:95. 403 
[13] Beckett WS, Jacobs DR, Xinhua YU, Iribarren C, Dale Williams O: Asthma is 404 
associated with weight gain in females but not males, independent of physical activity. Am J 405 
Respir Crit Care Med 2001, 164:2045–2050 406 
[14] Piipari R, Jaakkola JJK, Jaakkola N, Jaakkola MS: Smoking and asthma in adults. Eur 407 
Respir J 2004, 24:734–9. 408 
[15] Nakamura K, Nagata C, Fujii K, Kawachi T, Takatsuka N, Oba S, Shimizu H: Cigarette 409 
smoking and the adult onset of bronchial asthma in Japanese men and women. Ann Allergy 410 
Asthma Immunol 2009, 102:288–93 411 
[16] Centers for Disease Control and Prevention: The Health Consequences of Smoking-50 412 
Years of Progress. A Report of the Surgeon General. Atlanta, GA: 2014. 413 
[17] Becklake MR, Lalloo U: The ‘healthy smoker’: a phenomenon of health selection? 414 
Respiration 1990;57(3): 137–44 415 
[18] Butland B, Strachan D: Asthma onset and relapse in adult life: the British 1958 birth 416 
cohort study. Ann Allergy Asthma Immunol 2007;98:337–43. 417 
[19] Hedman L, Andersson M, Bjerg A, Forsberg B, Lundbäck B, Rönmark E: 418 
Environmental risk factors related to the incidence of wheeze and asthma in adolescence. Clin 419 
Exp Allergy 2015;45:184–91. 420 
[20] Verlato G, Accordini S, Nguyen G, Marchetti P, Cazzoletti L, Ferrari M, Antonicelli L, 421 
Attena F, Bellisario V, Bono R, Briziarelli L, Casali L, Corsico AG, Fois A, Panico M, 422 
Piccioni P, Pirina P, Villani S, Nicolini G, de Marco R: Socioeconomic inequalities in 423 
smoking habits are still increasing in Italy. BMC Public Health 2014;14:879. 424 
[21] Accordini S, Corsico AG, Cerveri I, Antonicelli L, Attena F, Bono R, Casali L, Ferrari 425 
M, Fois A, Marchetti P, Pirina P, Tassinari R, Verlato G, de Marco R: Diverging trends of 426 
chronic bronchitis and smoking habits between 1998 and 2010. Respir Res 2013;14:16. 427 
[22] Polosa R, Knoke JD, Russo C, Piccillo G, Caponnetto P, Sarvà M, Proietti L, Al-428 
Delaimy WK: Cigarette smoking is associated with a greater risk of incident asthma in 429 
allergic rhinitis. J Allergy Clin Immunol 2008;121:1428–34. 430 
[23] The GEIRD Study Group (de Marco R, Accordini S, Antonicelli L, Bellia V, Bettin 431 
MD, Bombieri C, Bonifazi F, Bugiani M, Carosso A, Casali L, Cazzoletti L, Cerveri I, 432 
Corsico AG, Ferrari M, Fois AG, Lo Cascio V, Marcon A, Marinoni A, Olivieri M, Perbellini 433 
L, Pignatti P, Pirina P, Poli A, Rolla G, Trabetti E, Verlato G, Villani S, Zanolin ME): The 434 
15 
 
Gene-Environment Interactions in Respiratory Diseases (GEIRD) Project. Int Arch Allergy 435 
Immunol 2010;152:255–63. 436 
[24] Olivieri M, Verlato G, Corsico A, Lo Cascio V, Bugiani M, Marinoni A, de Marco R: 437 
Prevalence and features of allergic rhinitis in Italy. Allergy 2002;57:600–6. 438 
[25] Verlato G, Melotti R, Corsico A, Bugiani M, Carrozzi L, Marinoni A, Dallari R, Pirina 439 
P, Struzzo P, Olivieri M, de Marco R: Time trends in smoking habits among Italian young 440 
adults. Respir Med 2006;100:2197–206. 441 
[26] de Marco R, Zanolin ME, Accordini S, Signorelli D, Marinoni A, Bugiani M, Lo Cascio 442 
V, Woods R, Burney P, on behalf of the ECRHS: A new questionnaire for the repeat of the 443 
first stage of the European Community Respiratory Health Survey: a pilot study. Eur Respir J 444 
1999;14:1044–8. 445 
[27] Olivieri M, Poli A, Zuccaro P, Ferrari M, Lampronti G, de Marco R, Lo Cascio V, 446 
Pacifici R: Tobacco smoke exposure and serum cotinine in a random sample of adults living 447 
in Verona, Italy. Arch Environ Health 2002;57:355–9. 448 
[28] Eagan TML, Bakke PS, Eide GE, Gulsvik A. Incidence of asthma and respiratory 449 
symptoms by sex, age and smoking in a community study. Eur Respir J 2002, 19:599–605. 450 
[29] Verlato G, Bortolami O, Accordini S, Olivieri M, Cappa V, Bugiani M, Corsico A, 451 
Pirina P, Villani S, de Marco R: Asthma in childhood reduces smoking initiation in 452 
subsequent teens among males. J Adolesc Heal 2011;48:253–8.  453 
[30] Bousquet J, Schünemann HJ, Samolinski B, Demoly P, Baena-Cagnani CE, Bachert C, 454 
et al. Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future 455 
needs. J Allergy Clin Immunol 2012;130:1049–62. 456 
[31] Burgess JA, Walters EH, Byrnes GB, Matheson MC, Jenkins MA, Wharton CL, Johns 457 
DP, Abramson MJ, Hopper JL, Dharmage SC: Childhood allergic rhinitis predicts asthma 458 
incidence and persistence to middle age: A longitudinal study. J Allergy Clin Immunol 459 
2007;120:863–9. 460 
[32] Van Hoecke H, Vandeplas G, Acke F, Thas O, De Sutter A, Gevaert P, Van 461 
Cauwenberge P, Dhooge I. Dissemination and Implementation of the ARIA Guidelines for 462 
Allergic Rhinitis in General Practice. Int Arch Allergy Immunol 2014; 163:106-13. 463 
[33] Verlato G, Melotti R, Olivieri M, Corsico A, Bugiani M, Accordini S, Villani S, 464 
Migliore E, Marinoni A, Pirina P, Carrozzi L, Bortolami O, Rava M, de Marco R: Asthmatics 465 
and ex-smokers respond early, heavy smokers respond late to mailed surveys in Italy. Respir 466 
Med 2010;104:172–9.  467 
16 
 
[34] Johannessen A, Verlato G, Benediktsdottir B, Forsberg B, Franklin K, Gislason T, et 468 
al.: Longterm follow-up in European respiratory health studies - patterns and implications. 469 
BMC Pulm Med 2014;14:63.   470 
 471 
  472 
17 
 
List of tables: 473 
Table 1: Baseline characteristics of non-asthmatics at baseline (n = 5,241), who did participate (n 474 
= 3,187) or did not participate (n = 2,054) in the follow-up. 475 
Table 2: Baseline characteristics of 3,167 responders to follow-up according to smoking habits at 476 
baseline.  477 
Table 3: Population at risk, new cases of asthma, cumulative incidence, crude and adjusted ORs 478 
of asthma onset as a function of baseline predictors.  479 
Table 4: Association between smoking habits and new onset of asthma, as a function of asthma-480 
like symptoms and allergic rhinitis.  481 
Table 5: Cumulative incidence of asthma and adjusted ORs, as a function of changes in smoking 482 




  487 
18 
 
Table 1: Baseline characteristics of non-asthmatics at baseline (n = 5,241), who did participate (n 488 
= 3,187) or did not participate (n = 2,054) in the follow-up. 489 
Characteristics  Respondents 
n (%) 
Non-respondents 
n (%)   
p value a 
Cohort 
 
 < 0.001 
     Verona - ISIA 1,174 (36.8) 343 (16.7) 
      Verona - ISAYA 1,285 (40.3) 610 (29.7) 
      Sassari - ISAYA 728 (22.8) 1,101 (53.6) 
 Sex 
 
 < 0.001 
    Male 1,442 (45.2) 1,149 (55.9) 
     Female  1,745 (54.8)  905 (44.1) 
 Age class (years) 
 
 < 0.001 
   [20 – 30) 830 (26.0) 750 (36.5) 
    [30 – 40) 1,336 (41.9) 881 (42.9)  
   [40 – 54) 1,021 (32.0) 423 (20.6)  
Occupation  
 
 < 0.001 
   Clerk 1,161 (36.6) 614 (30.4) 
    Housewife 364 (11.5) 182 (9.0) 
    Businessman   425 (13.4) 317 (15.7) 
    Unemployed 140 (4.4) 193 (9.6) 
    Workman 517 (16.3) 288 (14.3) 
    Student 251 (7.9) 232 (11.5) 
    Others 315 (9.9) 193 (9.6) 
 Asthma-like symptoms 
 
 0.023 
    No 2,709 (85.0) 1,697 (82.6) 
    Yes 478 (15.0) 357 (17.4) 
 Chronic bronchitis   < 0.001 
    No 2,855 (90.4) 1,758 (86.9)   
   Yes 303 (9.6) 265 (13.1)   
Allergic rhinitis   0.332 
    No 2,643 (83.6) 1,723 (84.7)  
   Yes 517 (16.4) 312 (15.3)   
Smoking   < 0.001 
    Never smoker 1,690 (53.4) 945 (46.3)  
    Ex-smoker 567 (17.9) 357 (17.5)  
    Current smoker 910 (28.7) 737 (36.1)   







Table 2: Baseline characteristics of 3,167 responders to follow-up according to smoking habits at 495 
baseline. Results are presented as absolute frequency with percentage in parentheses. 496 
 Never smokers 
(n = 1,690) 
Ex-smokers 
(n = 567) 
Current smokers 
(n = 910) 
p value a 
Cohort    0.002 
     Verona - ISIA 613 (36.3) 246 (43.4) 301 (33.1)  
     Verona - ISAYA 679 (40.2) 211 (37.2) 393 (43.2)  
     Sassari - ISAYA 398 (23.6) 110 (19.4) 216 (23.7)  
Sex    < 0.001 
     Male 660 (39.1) 297 (52.4) 476 (52.3)  
     Female  1,030 (60.9) 270 (47.6) 434 (47.7)  
Age at baseline (years)     < 0.001 
   [20 – 30) 491 (29.1)  69 (12.2) 269 (29.6)  
   [30 – 40) 724 (42.8) 243 (42.9) 357 (39.2)  
   [40 – 54) 475 (28.1) 255 (45.0) 284 (31.2)  
Occupation b    < 0.001 
     Clerk 650 (38.6) 190 (33.6) 316 (35.0)  
     Housewife 201 (11.9) 69 (12.2) 90 (10.0)  
     Businessman   196 (11.6) 93 (16.4) 132 (14.6)  
     Unemployed 85 (5.1) 14 (2.5) 40 (4.4)  
     Workman 224 (13.3) 117 (20.7) 172 (19.0)  
     Student 167 (9.9) 15 (2.7) 69 (7.6)  
     Others 160 (9.5) 68 (12.0) 85 (9.4)  
Asthma-like symptoms     < 0.001 
    No 1,530 (90.5) 489 (86.2) 673 (74.0)  
    Yes 160 (9.5) 78 (13.8) 237 (26.0)  
Chronic bronchitis b    < 0.001 
    No 1,587 (94.2) 509 (91.5) 745 (83.0)  
    Yes  98 (5.8) 47 (8.5) 153 (17.0)  
 
    
Allergic rhinitis b    <  0.001 
    No 1,365 (81.4) 477 (84.9) 782 (86.8)  
    Yes 312 (18.6) 85 (15.1) 119 (13.2)  
Information on smoking habits was missing in 20 subjects. 497 
a Significance of differences was evaluated by the Fisher’s exact test or the chi-squared test. 498 
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Table 3: Population at risk, new cases of asthma, cumulative incidence, crude and adjusted ORs 504 
of asthma onset as a function of baseline predictors.  505 
Covariates New cases of 
asthma / pop. at 







Adjusted OR a 
(95%CI)  
 
Cohort     
   Verona - ISIA 51/1,154 4.4 (3.4–5.8) 1 1 
   Verona - ISAYA 50/1,249 4.0 (3.0–5.2) 0.91 (0.61–1.34) 0.81 (0.68–0.98) 
   Sassari - ISAYA 44/720 6.1 (4.6–8.1) 1.41 (0.93–2.13) 1.27 (1.09–1.49) 
 
 p = 0.099 b   
Sex     
   Male 61/1,405 4.3 (3.4–5.5) 1 1 
   Female  84/1,718 4.9 (4.0–6.0) 1.13 (0.81–1.59) 1.18 (0.84–1.66) 
 
 p = 0.394   
Age class (years)     
   [20 – 30) 42/823 5.1 (3.8–6.8) 1 1 
   [30 – 40) 67/1,302 5.1 (4.1–6.5) 1.01 (0.68–1.50) 1.13 (0.75–1.70) 
   [40 – 54) 36/998 3.6 (2.6–5.0) 0.70 (0.44–1.10) 0.85 (0.66–1.08) 
 
 p = 0.159   
Occupation      
   Clerk 53/1,142 4.6 (3.6–6.0) 1 1 
   Housewife 15/355 4.2 (2.6–6.9) 0.91 (0.50–1.63) 0.88 (0.82–0.94) 
   Businessman 19/417 4.6 (2.9–7.0) 0.98 (0.57–1.68) 0.95 (0.70–1.30) 
   Unemployed 8/136 5.9 (3.0–11.4) 1.28 (0.60–2.76) 1.02 (0.52–2.00) 
   Workman 17/500 3.4 (2.1–5.4) 0.72 (0.41–1.26) 0.84 (0.32–2.23) 
   Student 16/249 6.4 (4.0–10.2) 1.41 (0.79–2.51) 1.15 (0.99–1.33) 
   Others 14/310 4.5 (2.7–7.5) 0.97 (0.53–1.78) 1.10 (0.68–1.79) 
 
 p = 0.625   
Asthma-like 
symptoms 
    
   No 106/2,654 4.0 (3.3– 4.8) 1 1 
   Yes 39/469 8.3 (6.1–11.2) 2.18 (1.49–3.19) 1.81 (0.84–3.89) 
 
 p < 0.001   
Chronic bronchitis     
   No 124/2,801 4.4 (3.7–5.3) 1 1 
   Yes 19/294 6.5 (4.2–9.9) 1.49 (0.91–2.46) 0.93 (0.59–1.44) 
 
 p = 0.080   
Allergic rhinitis     
    No  82/2,589 3.2 (2.6–3.9) 1 1 
   Yes 61/507 12.0 (9.5–15.2) 4.18 (2.96–5.91) 4.00 (3.68–4.35) 
 
 p < 0.001   
Smoking habits     
   Never smoker 76/1,666 4.6 (3.7–5.7) 1 1 
   Ex-smoker 30/554 5.4 (3.8–7.6) 1.20 (0.78–1.85) 1.28 (1.09–1.49) 
   Current smoker  39/883 4.4 (3.2–6.0) 0.97 (0.65–1.43) 1.01 (0.66–1.53) 
  p = 0.641   
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The analysis was performed on 3,123 subjects, as information on asthma onset was missing in 64 506 
subjects. Significant estimates (p < 0.05) are reported in bold. 507 
a Adjusted for all the other variables in the model. 508 
b p values were computed by the Fisher’s exact test. 509 
 510 
Table 4: Association between smoking habits and new onset of asthma, as a function of asthma-511 
like symptoms and allergic rhinitis. Odds ratios and p values were computed by a logistic 512 
regression model, controlling for study cohort, gender, age group, occupation and chronic 513 
bronchitis. 514 
  
ORs (95% CI) p value a 
  
Never smoker Ex-smoker Current smoker 
 Asthma-like 
symptoms 
No 1 0.97 (0.82–1.15) 1.23 (0.61–2.46) 0.609 
Yes 1.77 (0.94–3.34) 4.46 (2.36–8.44) 1.23 (0.59–2.59)  
Allergic 
rhinitis  
No 1 1.00 (0.51–1.96) 1.09 (0.68–1.74) 0.840 
Yes 3.83 (3.09–4.74 ) 6.80 (4.34–10.66) 3.14 (2.39–4.14)  
Significant estimates (p < 0.05) are reported in bold. 515 
a  p values were computed by the Wald test. 516 
 517 
Table 5: Cumulative incidence of asthma and adjusted ORs, as a function of changes in smoking 518 
habits during the follow-up.   519 
Changes in 
smoking habits 
New cases / 
Population at risk  
Cumulative incidence  
(95% CI) 
ORs (95%CI) a  
Never smoker 75/1,564 4.8 (3.8–6.0) 1 
Ex-smoker 25/513 4.9 (3.3–7.1) 1.02 (0.72–1.45) 
Starter & relapse 5/105 4.8 (2.0–11.0) 0.96 (0.36–2.56) 
Quitter 12/266 4.5 (2.6–7.8) 0.96 (0.44–2.10) 
Current smoker 26/569 4.6 (3.1–6.6) 0.98 (0.60–1.59) 
a ORs were computed by a logistic regression model, adjusting for cohort, sex, age class, 520 
occupation and respiratory disorders (asthma-like symptoms, chronic bronchitis, allergic rhinitis). 521 
 522 
